AMP is the leading organization in the field of molecular diagnostics, and the AMP Annual meeting is the premier gathering of molecular professionals. As technologies change and new challenges arise, members and non-members alike rely on the AMP meeting to obtain the critical information needed to ensure that their patients receive the best care and best results.

This collection contains downloadable PDF slides of many of the presentations given during the AMP 2018 Annual Meeting and Expo. See the "topics" tab for a list of all the presentations for which slides are available.

 

The digital files (PDFs) for the AMP 2018 Annual Meeting are:

  • Free for all AMP members until February 15, 2019. After February 15, 2019 (11:59PM EST), the price increases to $99.00.
  • Free for Non-members who registered for the meeting. They will be emailed a coupon code valid until February 15, 2019.

 

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

How to Access the Presentation Slides

  1. On the menu to the right, click on "add to basket"
  2. Log in using your AMP credentials.
  3. The system will automatically check your membership status and provide the correct price. Add coupon code if applicable.
  4. Check out.
  5. Click here for instructions on how to access the presentation slides.

 

Join the AMP Family for a discount on this item.

Course Information
Course Date:
November 01, 2018
Click on a topic name to see details and purchase options.
Thursday November 1, 2018

AMP Annual Meeting 2018 - Program Book

Genomics of Pediatric AML and MDS

Jeffery Klco, MD, PhD, St Jude Children's Research Hospital, Memphis, TN, USA

Large Indel Detection in Clinical NGS Assays
Sabah Kadri, PhD, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA

Vincent Magrini, PhD, Institute for Genomic Medicine (IGM) at Nationwide Children's Hospital, Columbus, OH, USA

Catherine E. Cottrell PhD PhD, Nationwide Children's Hospital, Columbus, OH, USA

 

Validation of the Karius Microbial Cell-free DNA Sequencing Test for Infectious Disease
Timothy A. Blauwkamp, PhD, Karius, Inc., Redwood City, CA, USA

A Smart Diagnostic: Technology that Learned to Identify and Count Individual Bacteria in Blood
Stephanie I. Fraley, PhD, University of California, San Diego, CA, USA 
speaker did not provide permission to share slides

Occurrence of Medulloblastoma in a Patient with Curry-Jones Syndrome
Binu Porath, PhD, Children's Mercy Hospital, Kansas City, MO, USA

Identification of a Novel Likely Pathogenic PIK3R1 Variant by Targeted Next-Generation Sequencing Analysis in a Patient with Overgrowth Syndrome and Lymphatic Malformation
Christopher Suciu, MD, MS Washington University School of Medicine in St. Louis, St. Louis, MO, USA

Sex Check: Verifying Patient Sex Based on Off-Panel SNPs on the X Chromosome
Jennifer Bynum, MD, Johns Hopkins, Baltimore, MD, USA

A Discrepancy Between the Human Reference Genome (GRCh37) and Transcriptome (RefSeq) Results in the Incorrect Annotation of a Clinically-Relevant Sequence Variant in RECQL4
Lisa Lansdon, PhD, Children's Mercy Kansas City, Kansas City, MO, USA

Jonathan Rothberg, PhD, Founder, Chairman, and CEO of Butterfly Network, Inc. CT, USA

Newborn Genomic Sequencing for Diagnosis and Screening
Jonathan S. Berg, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

The Babyseq Project: A Study of Newborn Genomic Sequencing
Ingrid A. Holm, MD, MPH, Boston Children's Hospital/Harvard Medical School, Boston, MA, USA

Challenges of Variant Interpretation: Sources of Variability among VITAL Participants
Elaine Lyon, PhD, Hudson Alpha, Huntsville, AL, USA 
speaker did not provide permission to share slides

ClinVar and ACMG Variant Classification Standards for Inherited Cardiovascular Disease
Birgit Funke, PhD, Veritas Genetics, Danvers, MA, USA 
Harvard Medical School, Boston, MA, USA
speaker did not provide permission to share slides 

Viral Genomics in the Clinical Lab
Alex Greninger, MD, PhD, University of Washington, Seattle, WA, USA

NGS for Natural Disasters
Randall Olsen, MD, PhD, Houston Methodist Hospital and Research Institute, Houston, TX, USA

Leveraging Computer Infrastructure to Scale Clinical Bioinformatics
Elaine Gee, PhD, BigHead Analytics Group, Windsor, CA, USA

Standards and Apps for Genomic Decision Support
Jeremy L. Warner, MD, MS, Vanderbilt University, Nashville, TN, USA

(Sponsored by the AMP Economic Affairs Committee)

Laurence J. Clark, MD, National Government Services, E. Syracuse, NY, USA

Paul B. Gerrard, MD, Palmetto GBA, Columbia, SC, USA

Charles Matthews, ClearView Health Partners, Newton, MA, USA

Gabriel Bien-Willner, MD, Palmetto GBA, Columbia, SC, USA

Michael Fine, MD, Health  Net, Laguna Beach, CA, USA

Elizabeth Swisher, MD, University of Washington, Seattle, WA, USA

Stephen Lincoln, Invitae, San Francisco, CA, USA

Eric H. Bernicker, MD, Houston Methodist Hospital, Houston, TX, USA

Valentina Nardi, Massachusetts General Hospital, Boston, MA, USA

Jonathan A. Nowak, MD, PhD, Brigham and Women's Hospital, Boston, MA, USA

Angela Jacobson, MS, University of Washington, Seattle, WA, USA

Spliceosome Gene Mutations in MDS
Matthew Walter, MD, Washington University, St. Louis, MO, USA

Inherited Hematopoietic Malignancies
Lucy A. Godley, MD, PhD, The University of Chicago, Chicago, IL, USA

Are Meningitis/Encephalitis Panels Ready for Prime Time?
Kevin Alby, PhD, University of Pennsylvania, Philadelphia, PA, USA

Point-Counterpoint: Molecular Diagnosis of Meningitis/Encephalitis
Jennifer Dien Bard, PhD, Children's Hospital Los Angeles, Los Angeles, CA, USA
University of Southern California, Los Angeles, CA, USA

Friday November 2, 2018

Barbara A. Zehnbauer, PhD, Emory University School of Medicine, Atlanta, GA, USA

Visualizations for Genomic Data, the GTEx Experience
Jared L. Nedzel, Broad Institute, Cambridge, MA, USA

Katherine Huang, Broad Institute, Cambridge, MA, USA

(Sponsored by the Professional Relations Committee)

Jill Hagenkord, MD, Color Genomics, Burlingame, CA, USA

Elissa Levin, MS, Helix, San Francisco, CA, USA

Danielle Bonadies, MS, My Gene Counsel, Branford, CT, USA

Altovise Ewing, PhD, 23and Me , Mountain View, CA, USA

Circulating Tumor DNA (ctDNA) Detection in CSF in a Patient with Metastatic Melanoma to the CNS
Andres Moon, MD, University of Washington, Seattle, WA, USA

An Unusual Driver Mutation in a Lung Adenocarcinoma
Erik Nohr, MD, Stanford Healthcare, Palo Alto, CA, USA

LMNA/NTRK1 Fusion in a Paravertebral Soft Tissue Mass
Yulei Shen, MD, PhD, Baylor College of Medicine, Houston, TX, USA

Recurrent Glioblastoma with Primary and Secondary Features in a Patient with a Deficiency of Mismatch Repair
Martin Powers, MD, University of California San Diego, San Diego, CA, USA

Use of Molecular Testing to Predict Gonorrhea Treatment 
Jeffrey D. Klausner, MD, MPH, University of California, Los Angeles, CA, USA

Value of Molecular AST Methods for Bacteria: Are We There?
Romney M. Humphries, PhD, Accelerate Diagnostics, Tucson, AZ, USA

Predictor of Response to PARP Inhibitors
Elizabeth M. Swisher, MD, University of Washington, Seattle, WA, USA

Leveraging Personalized Medicine for Diagnosis and Treatment of Pancreatic Cancer
Brian Wolpin, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, USA

G044 - Designing and Implementing NGS Tests for Inherited Disorders – a Practical Framework with Step-by-Step Guidance for Clinical Laboratories
Avni B. Santani, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, USA

G025 - Verification of Very Small Copy Number Variants (Micro CNVs) Detected on Whole Genome CMA Analysis and Implications for Clinical Reporting
Ulrike P. Kappes, MPH, MD, PhD, Medical College of Wisconsin, Milwaukee, WI, USA

G026 - Two-site Evaluation of a One-tube PCR/CE Assay that Resolves CAG Length Polymorphisms in Exon 1 of the HTT Gene
Sarah Statt, PhD, Asuragen, Austin, TX, USA

G021 - Brazilian Panorama of Whole Exome: Details of 315 Cases
Roberta Sitnik, PhD, Hospital Israelita Albert Einstein, São Paulo, Brazil

H025 - Ultradeep Error Corrected Next-generation Sequencing (NGS) of ABL1 Kinase Domain Mutations in BCR-ABL1 Positive Malignancies
Nikhil Patkar, MD, Tata Memorial Center, Mumbai, Maharashtra, India

H041 -  Longitudinal Monitoring of AML Tumors with High-throughput Single-Cell DNA Sequencing Reveals Rare Clones Prognostic for Disease Progression and Therapy Response
Dennis J. Eastburn, PhD, Mission Bio, Inc., South San Francisco, CA, USA

H014 - Mate Pair Sequencing: Ushering Cytogenetics Into the Era of Personalized Medicine
Nicole Hoppman, PhD, Mayo Clinic, Rochester, MN, USA

H039 - Donor-derived Clonal Hematopoiesis of Indeterminant Potential Mutations are Detected in Transplant Recipients after Allogeneic Hematopoietic Stem Cell Transplant
Jennifer Dunlap, MD, Oregon Health & Science University, Portland, OR, USA

ID004 - Evaluation of a Novel Isothermal Amplification Assay for Detection and Genotyping of Human Papillomavirus in Formalin-fixed Paraffin-embedded Tissue of Oropharyngeal Carcinomas
Yi-Wei Tang, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

ID012 - Comprehensive Solid Tumor Microbiome Profiling via Analysis of Unmapped Reads in Large Panel, Hybridization Capture-based NGS Assay Data
Chad M. Vanderbilt, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

ID063 - A Quantitative, Multiplexed RNA Detection Platform for Rapid Pathogen Identification and Phenotypic Antibiotic Susceptibility Testing (AST) using NanoString(™) Technology
Roby P. Bhattacharyya, MD, PhD, Broad Institute, Cambridge, MA, USA
Massachusetts General Hospital, Boston, MA, USA

ID007 - The Diagnostic Yield of Universal Pathogen Detection by Next-Generation Sequencing Compared to the Standard of Care in Patients with Pneumonia
Brittany A. Young, MD, PhD, University of Utah, Salt Lake City, UT, USA

I025 - Identification of Viral Integration Sites in Cancer Genomes using Unmapped Reads in Targeted Next-Generation Sequencing Data
Anita S. Bowman, MS, Memorial Sloan Kettering Cancer Center, New York, NY, USA

I027 - Detection of Microsatellite Instability Using a Large Next-generation Sequencing Panel Across Diverse Tumor Types
Susan J. Hsiao, MD, PhD, Columbia University Medical Center, New York, NY, USA

I009 - Personalized Transcriptomic Drug Profiling in Non-small Cell Lung Cancer
Zachary Abrams, PhD, The Ohio State University, Athens, OH, USA

I034 - Assessing Cancer Diagnosis From Clinical Genomics Data Using Machine Learning 
Paul R. Hess, MD, PHD, University of Pennsylvania, Philadelphia, PA, USA

ST002 - Analysis of Urinary Cell-free DNA for Early Detection and Surveillance of Bladder Cancer
Jonathan Dudley, MD, Stanford University, Stanford, CA, USA

ST055 - DNA Sequencing of Human, Epstein-Barr Virus, and Helicobacter Pylori Genomes to Classify and Monitor Gastric Adenocarcinoma
Margaret L. Gulley, MD, University of North Carolina, Chapel Hill, NC, USA

ST107 - Clinical Validation of MSK-ACCESS: An Ultrasensitive Next-generation Sequencing Assay for Liquid Biopsies in the Clinic
A. Rose Brannon, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

ST144 - Prognosis Determined by Tumor Mutational Burden (TMB) Using Whole Exome Sequencing (WES)
Evan Fernandez, MS, Weill Cornell Medicine, New York, NY, USA

Microbiome Changes with Infectious Complications During Stem Cell Transplantation
Ying Taur, MD, MPHMemorial Sloan Kettering Cancer Center, New York, NY, USA

The Intestinal Virome: From Chronic Inflammation to Bacteriophage Therapy Targeting Multidrug Resistant Bacteria
Breck A. Duerkop, PhD, University of Colorado School of Medicine, Aurora, CO, USA

CRISPR/Cas9 Targeting and Inactivation of Viral DNA Genomes
Bryan R. Cullen, PhD, Duke University Medical Center, Durham, NC, USA

Programmable RNA-targeting CRISPR-Cas Enzymes for RNA Detection and Therapeutics
Mitchell R. O'Connell, PhD, University of Rochester, Rochester, NY, USA

Robert L. Nussbaum, MD, Invitae Corporation, San Francisco, CA, USA

Wayne W. Grody, MD, PhD, University of California, Los Angeles, CA, USA

"In Silico" Proficiency Testing
John D. Pfeifer, MD, PhD, Washington University School of Medicine, St. Louis, MO, USA

In Silico Proficiency Testing for Clinical Next Generation Sequencing
Karl V. Voelkerding, MD, University of Utah School of Medicine, Salt Lake City, UT, USA

Saturday November 3, 2018

Thomas W. Prior, PhD, Case Western Reserve University, Cleveland, OH, USA

Jeremy Segal, MD, PhD, University of Chicago, Chicago, IL, USA

Dara Aisner, MD, PhD, University of Colorado, Denver, CO, USA

Identification of a Rare Germline POT1 Mutation by Targeted Next-Generation Sequencing of a Splenic Marginal Zone Lymphoma
Audrey Jajosky, MD, PhD, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Identification of Acute Leukemia Risk Mutations in a Child with Severe Congenital Neutropenia
Jennifer Yoest, MD, Washington University School of Medicine in St. Louis, St. Louis, MO, USA              

Whole Genome Sequencing Identifies Cryptic High-Risk Cytogenetic Findings In A Patient With Acute Myeloid Leukemia
Michael Alberti, MD, PhD, Washington University School of Medicine in St. Louis, St. Louis, MO, USA

A Case of Myeloid Neoplasm with Germline Predisposition: Connecting the Clinical, Laboratory, Morphology and Molecular Dots
Fatima Zahra Jelloul, MD, MD Anderson Cancer Center, Houston, TX, USA

TT074 - Multi-Patient Longitudinal Monitoring of Cancer Mutations from Circulating DNA of Using Personalized Single Color Digital PCR Assays
Christina M. Bouwens, Stanford University, Stanford, CA, USA

TT059 - Cell-free DNA Allograft Rejection Monitoring Using Low-coverage Whole Genome Sequencing
Niklas Krumm, MD, PhD, University of Washington, Seattle, WA, USA

TT070 - Universal Design and Rapid PCR for Genotyping by High Resolution Melting
Jessica Houskeeper, MRes , University of Utah, Salt Lake City, UT, USA

TT046 - The NIH Genetic Testing Registry (GTR): Test Methodologies as a Sensor of the Precision Medicine Environment
Adriana Malheiro, MS, National Center for Biotechnology Information, NIH, Bethesda, MD, USA

Opportunities and Challenges in Laboratory Stewardship: Leaders Apply Here
Gary Procop, MD, Cleveland Clinic, Cleveland, OH, USA

Artificial Intelligence in Cancer Genomics and Therapy
Olivier Elemento, PhD, Weill Cornell Medicine - Englander Institute for Precision Medicine, New York, NY, USA

Probabilistic Graphical Models for Integrative Analysis of Pathomics Data
Panagiotis Benos, PhD, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Clinical Applications of Digital PCR 
Maria Arcila, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Liquid Biopsy for Solid Tumors: Promises and Perils
Mark Routbort, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Cancer Genomics Visualization across Scales: Nucleotides to Cohorts
Nils Gehlenborg, PhD, Harvard Medical School, Boston, MA, USA

Data Commons for Precision Cancer Medicine
Ethan Cerami, PhD, Dana-Farber Cancer Institute, Boston, MA, USA

The Role of Enterovirus D68 in Acute Flaccid Myelitis
Kevin Messacar, MD, University of Colorado/Children's Hospital Colorado, Aurora, CO, USA

Epidemiology, Surveillance, and Diagnosis of Enterovirus D68
Samuel Dominguez, MD, PhD, University of Colorado/Children's Hospital Colorado, Aurora, CO, USA

Innovations and Transitions in ABMGG's Continuing Certification Program
Cecily P. Marroquin, American Board of Medical Genetics & Genomics, Rockville, MD, USA

Fellowship Training and Continuing Certification in Molecular Pathology
Karen L. Kaul, MD, PhD, NorthShore University Health System, Evanston, IL, USA

AMP Guidelines for Validating Next Generation Sequencing Bioinformatics Pipelines
Somak Roy, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Alexis B. Carter, MD, Children's Healthcare of Atlanta, Atlanta, GA, USA

Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia
Jennifer A. Woyach, MD, The Ohio State University, Columbus, OH, USA

Towards a Genomic Classification of T Cell Malignancies: Opportunities for Precision Medicine
Megan S. Lim, MD, PhD, University of Pennsylvania, Philadelphia, PA, USA

Christopher E. Mason, PhD, Weill Cornell Medicine, New York, NY, USA

Clinical Implications of Mutational Load and Signatures on Replication Repair Deficiency in Cancer
Uri Tabori, MD, PhD, Hospital for Sick Children, Toronto, Ontario, Canada

Hypermutation in Cancer: Burden and Signatures of Mutational Processes
Ahmet Zehir, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Individual topic purchase: Selected
Products
Online Materials
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $599.00